论文部分内容阅读
Patients with hepatocellular carcinoma(HCC)often experience hepatic morbidity.Hepatitis B virus(HBV)reactivation is well documented as a serious hepatic morbidity during anti-cancer therapy.Reported rates of HBV reactivation in chronic carriers with HCC u